Summary. D600 (2 to 20 ~tM; a-isopropyl-a [(Nmethyl-N-homoveratril)-y-aminopropyl]-3,4,5 -trimethoxyphenyl-acetonitril) caused a dose-related, rapid and reversible inhibition of glucose-induced insulin release. It also suppressed the insulinotropic action of a sulphonylurea but failed to affect the enhancing action of theophylline upon glucose-induced release. The inhibitory effect of D600 was enhanced at low extracellular Ca 2+ concentration. D600 reduced both basal and glucose-stimulated 45calcium net uptake, whilst failing to affect the efflux of 45calcium from perifused islets. The recognition of glucose by the B-cell was also unaffected by D600 as judged by the effect of the sugar upon both 4%alcium efflux and net uptake in the isolated islets. These findings are compatible with the hypothesis that the primary mode of action of D600 is to inhibit Ca 2 § entry in the B-cell.
If the Ca 2+ dependency of insulin release is well documented, the precise influence of insulinotropic agents upon the movements of Ca 2+ in the B-cell requires further investigation. In the search for specific tools to interfere with the handling of Ca 2+ by islets tissue, we are presently investigating the insular effects of various potential Ca 2+-agonists and antagonists [1] [2] [3] . The present study, already partially reported in abstract form [4] , deals with the effect of D600 (a-isopropyl-a [(N-methyl-N-homoveratril)-vaminopropyl]-3, 4, 5-trimethoxyphenyl-acetonitril) upon physiological events in the endocrine pancreas.
* (a -isopropyl-a [(N-methyl-N-homoveratril) -7-

aminopropyl] -3, 4, 5-trimethoxyphenyl-acetonitril)
Materials and Methods
The method used for the measurement of insulin release by either isolated islets [5] or the isolated perfused pancreas [6] removed from fed rats, and for the uptake [7] and efflux of 45calcium [8] in the isolated islets are described in detail elsewhere. D600 (Knoll A.G., Ludwigshafen, FRG) was a gift of Dr. J.J. Dreifuss (Department of Physiology, Geneva University).
Results
Effect olD600 upon Insulin Release by Isolated Islets
D600 (2 to 20 ~M) caused a dose-related inhibition of glucose-induced insulin release in isolated islets, rates of secretion close to the basal value normally found in the absence of glucose being observed at a D600 concentration of 20 gM (Fig. 1) . A reduction in the Ca 2+ concentration of the incubation medium sensitized the B-cell to the inhibitory effect of D600, so that suppression of insulin release to basal value was now observed with as little as 2 ~tM D600. Theophylline, on the contrary, apparently antagonized the inhibitory effect of the calcium-antagonist. Thus, at the usual Ca 2+ concentration (2.0 mEq/1), the enhancing effect of theophylline upon glucose-induced insulin release displayed an invariable relative magnitude whether in the absence (enhancing action: • 2.57) or presence of D600 in concentrations of 2 ~tM (• 2.59) and 10 ~tM (• 2.76). Moreover, at a subnormal Ca 2+ concentration (0.5 mEq/1) and in the presence of theophylline, the rates of glucose-induced insulin release, whether in the absence or presence of D600 (2 ~tM), were similar or somewhat higher than the cortes- 
Effect of D600 upon Insulin Release by the Isolated Perfused Pancreas
The method of the isolated perfused pancreas was used to investigate the effect of D600 upon the dynamics of insulin release. D600 inhibited in a dosedependent fashion both the early peak and later buildup in secretion rate evoked by glucose (Fig. 2) . The short-lived secretory peak evoked by gliclazide at a low glucose concentration was also abolished by D600 (Fig. 3) . At two calcium levels (2 and 4 mEq/1), the inhibitory effect of the calcium-antagonist was almost immediate and at least partially reversible (Fig. 4) .
Effect of D600 upon 45Calcium Net Uptake D600 (2 to 10 txM) significantly inhibited (P < 0.005 or less) both basal and glucose-induced 45calcium net uptake at normal Ca 2+ concentration (2.0 mEq/1), However, the stimulant action of glucose upon Ca 2+ net uptake relative to basal value was not less marked in the presence of D600 (4 IxM) than in its absence (Table 1) . When the extracellular Ca 2+ concentration was lowered to 0.5 mEq/1, the net uptake of 45calcium found in the absence of D600 was less than at normal Ca 2+ concentration (P < 0.025), and addition of the calcium-antagonist to the incubation medium provoked a further dose-related reduction (P < 0.02 or less). Comparison of the data for insulin release ( Fig. 1 ) and calcium uptake (Table 1) indicated that the interaction of glucose, extracellular Ca 2+ and D600 upon these two parameters of islet function did not alter their normal relationship as previously observed in the present system (7, 9) . This relationship (Fig. 5) is characterized by the fact that insulin output increases above its basal value when the size of the Ca 2+ exchangeable pool exceeds half of its normal value at high glucose concentration (16.7 mM).
Effect of D600 upon 4s Calcium Efflux
D600 failed to cause any obvious alteration in the pattern of 45calcium efflux from perifused islets exposed to CaZ+-depleted media, whether in the presence or absence of glucose (Fig. 6) . The Ca2+-antagonist did not suppress the normal fall in effluent radioactivity caused in the present system by the addition of glucose to the peffusate (Fig. 7) .
Discussion
The present data, which complement our study with verapamil (1-3), suggest that D600 does not affect the process by which the B-cell recognizes glucose as an insulinotropic agent, since both the inhibition of Ca 2 + efflux ( Fig. 7) and subsequent relative increase in Ca 2+ net uptake (Table 1) normally evoked by glucose were not altered in the presence of the Ca 2+-antagonist, although the drug was used at a concentration sufficient to cause marked inhibition of insulin release ( Figs. 1 and 2 ). These findings and the fact that D600 also suppressed gliclazide-induced insulin release ( Fig. 3) could indicate that the drug acts upon the secretory sequence at a level distal to the site of recognition of the secretagogues. Our results are compatible with the idea that D600 inhibits Ca 2+ inward transport in the B-cell, since it inhibited the net uptake without facilitating the efflux of 4%alcium in the isolated islets. The postulated primary action of D600 on Ca 2+ inward transport would also explain why the Ca2+-antagonist inhibited basal net uptake of 45calcium, accentuated the depressing effect of a reduced extracellular Ca 2 + concentration upon both Ca 2+ net uptake and insulin release, and failed to affect the insulinotropic action of theophylline ( Fig. 1 and Table 1 ), which is thought to augment glucose-induced insulin release by causing an intracellular translocation rather than a net accumulation of Ca 2+ in the B-cell [10, 11] .
If our assumption is correct that D600 inhibits calcium entry in the B-cell like in other tissues [12] [13] [14] , the rapidity of its inhibitory effect upon insulin release (Fig. 4) would suggest that the physiologi- 7 . Effect of glucose (16.7 raM) added at the time shown by the vertical dotted line) upon 4Scalcium efflux from islets perifused in the presence of D600 (2 ~tM), the perifusion media being deprived of Ca 2+ and enriched with EGTA (1 mM). Same presentation as in Fig. 6 cally active pool of Ca 2+ in the B-cell is characterized by a rapid turn-over rate so that, under many if not all experimental conditions, a sufficient inward transport of Ca 2+ would represent, to say the least, a permissive factor for the maintenance of the calcium-dependent insulin secretory process.
